GREENWOOD VILLAGE, Colo., April 1, 2011 /PRNewswire/ — Ampio
Pharmaceuticals, Inc. (OTC Bulletin Board:
AMPE) (“Ampio”) announced today that Mark D. McGregor will be
appointed to the position of Chief Financial Officer and Corporate
Secretary effective April 4, 2011. Mr. Bruce G. Miller, who served
in these capacities since April 2010, will be joining the team that
will advance the commercialization of Zertane, Ampio’s product
candidate that was the subject of a 2009 and 2010 Phase 3
multicenter clinical trial in Europe and was obtained through our
acquisition of DMI BioSciences, Inc. Mr. Miller was with DMI
BioSciences since 1992, having served as Chief Executive Officer
and/or President throughout this period.

Mr. McGregor, a Certified Public Accountant, is a highly
experienced financial executive with in-depth experience in
treasury and risk management, including developing financial
strategic plans, cash management and investments, managing foreign
currency and interest rate exposures, credit provider and credit
rating agency relations, and insurance risk management. His prior
experience also encompasses:

• corporate and international consolidation and reporting,
• SEC and management reporting,
• financial integration,
• disbursements operations,
• evaluating potential acquisitions,
• conducting financial due diligence,
• negotiating credit line provisions to promote operating
  flexibility,
• optimizing capital structures, and
• implementing stock buy-back programs to enhance stockholder
  value.

Mr. McGregor’s career spans over 30 years of financial
experience in a variety of industries. For 20 years he was with
Storage Technology Corporation, a public international information
and storage technology company with $2 billion in annual worldwide
revenues, where he served

‘/>”/>

SOURCE